The Basser Center for BRCA hosts events throughout the year, including signature panels and programs, webinars led by leading researchers, and fundraising events.

Past Events

Family Reunions: The Family Health History Conversation

In honor of Black Family Cancer Awareness Week, The Basser Center’s Black & BRCA initiative held a virtual panel discussion focused on the importance of having the family cancer history conversation. Hear from breast cancer previvor Erika Stallings, breast cancer survivors Lyndsay Levingston, and Mica Anders, and Penn Medicine clinical research nurse Jessica Savage-Jones. The discussion will be moderated by Basser Young Leadership Council member Ashley Dedmon. 

Basser Center Annual Research Update Webinar 2022

In the Basser Center's Annual Research Webinar, Executive Director Susan Domchek, MD, shares a look back at the advances made in BRCA-related cancer research over the past year, and highlights important work that will be ongoing in 2022.

"This Boy We Made": A Conversation with Author Taylor Harris

Basser Young Leadership Council co-chair Erika Stallings, Esq. in conversation with BRCA mutation carrier and advocate Taylor Harris, author of "This Boy We Made": A Memoir of Motherhood, Genetics, and Facing the Unknown. Taylor discusses navigating health and education systems as a Black mother, her young son’s medical challenges, and how all of those experiences have helped to shape her life. 

Men & BRCA Educational Panel

A panel discussion focused on men and BRCA gene mutations, including risk factors and surveillance options. Hear from BRCA mutation carrier and advocate, Gary Fuhrman, Penn Medicine physician Vivek Narayan, MD, MSCE, and Basser Genetic Counselor Avi Anantharajah, MS, LCGC. The discussion was moderated by Basser Young Leadership Council member Louis Abrams, Esquire.

Our BRCA Journeys: A Storytelling Event

Susan Domchek, MD, moderated this Central Synagogue panel with individuals across various communities discussing their BRCA mutations and the steps they have taken to reduce their risk.